Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119817887 | 11981788 | 7 | F | 20151112 | 20160718 | 20160201 | 20160721 | EXP | DE-AMGEN-DEUSP2016010100 | AMGEN | 0.00 | M | Y | 0.00000 | 20160721 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119817887 | 11981788 | 1 | PS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 1 IN 14 D | 12 | MG | 125031 | 6 | MG | UNKNOWN FORMULATION | QOW | ||||
| 119817887 | 11981788 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 740 MG, 1 IN 14 D | 2604.80005 | MG | 0 | 740 | MG | SOLUTION FOR INFUSION | QOW | ||||
| 119817887 | 11981788 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1500 MG, 1 IN 14 D | 4907.60889 | MG | 0 | 1500 | MG | QOW | |||||
| 119817887 | 11981788 | 4 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 100 MG, 1 IN 1 D | 4300 | MG | 0 | 100 | MG | QD | |||||
| 119817887 | 11981788 | 5 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 1 MG, 1 IN 14 D | 3.2720001 | MG | 0 | 1 | MG | QOW | |||||
| 119817887 | 11981788 | 6 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 587.5 MG, 1 IN 14 D | 2041.41394 | MG | 0 | 587.5 | MG | QOW | |||||
| 119817887 | 11981788 | 7 | SS | METHOTREXATE DISODIUM | METHOTREXATE SODIUM | 1 | Intravenous (not otherwise specified) | 3000 MG, BEFORE + AFTER R-CHOP (300 MG) | 0 | 3000 | MG | ||||||||
| 119817887 | 11981788 | 8 | SS | LEUCOVORIN /00566701/ | LEUCOVORIN | 1 | Oral | 30 MG, UNK | 0 | 30 | MG | ||||||||
| 119817887 | 11981788 | 9 | SS | LENOGRASTIM | LENOGRASTIM | 1 | Subcutaneous | 34 MIOE, 14 DAILY | 0 | ||||||||||
| 119817887 | 11981788 | 10 | C | BISOPROLOL HEMIFUMARATE | BISOPROLOL FUMARATE | 1 | Oral | 1.25 MG, 1 IN 1 D | 0 | 1.25 | MG | QD | |||||||
| 119817887 | 11981788 | 11 | C | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0.4 MG, 1 IN 1 D | 0 | .4 | MG | QD | |||||||
| 119817887 | 11981788 | 12 | C | TORASEMIDE | TORSEMIDE | 1 | Oral | 10 MG, 1 IN 1 D | 0 | 10 | MG | QD | |||||||
| 119817887 | 11981788 | 13 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, 1 IN 1 D | 0 | 300 | MG | QD | |||||||
| 119817887 | 11981788 | 14 | C | INSULIN | INSULIN NOS | 1 | Subcutaneous | UNK, AS INDICATED/ PALN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119817887 | 11981788 | 1 | B-cell lymphoma |
| 119817887 | 11981788 | 2 | B-cell lymphoma |
| 119817887 | 11981788 | 3 | B-cell lymphoma |
| 119817887 | 11981788 | 4 | B-cell lymphoma |
| 119817887 | 11981788 | 5 | B-cell lymphoma |
| 119817887 | 11981788 | 6 | B-cell lymphoma |
| 119817887 | 11981788 | 7 | B-cell lymphoma |
| 119817887 | 11981788 | 8 | B-cell lymphoma |
| 119817887 | 11981788 | 9 | B-cell lymphoma |
| 119817887 | 11981788 | 10 | Hypertension |
| 119817887 | 11981788 | 11 | Hypertension |
| 119817887 | 11981788 | 12 | Hypertension |
| 119817887 | 11981788 | 13 | Prophylaxis |
| 119817887 | 11981788 | 14 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119817887 | 11981788 | HO |
| 119817887 | 11981788 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119817887 | 11981788 | Febrile infection | |
| 119817887 | 11981788 | Febrile neutropenia | |
| 119817887 | 11981788 | Palmar-plantar erythrodysaesthesia syndrome | |
| 119817887 | 11981788 | Pulmonary thrombosis | |
| 119817887 | 11981788 | Pyrexia | |
| 119817887 | 11981788 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119817887 | 11981788 | 1 | 20151019 | 20151102 | 0 | |
| 119817887 | 11981788 | 2 | 20151015 | 20160127 | 0 | |
| 119817887 | 11981788 | 3 | 20151016 | 20160115 | 0 | |
| 119817887 | 11981788 | 4 | 20151016 | 20160115 | 0 | |
| 119817887 | 11981788 | 5 | 20151016 | 20160115 | 0 | |
| 119817887 | 11981788 | 6 | 20151016 | 20160122 | 0 | |
| 119817887 | 11981788 | 7 | 20151008 | 20160128 | 0 | |
| 119817887 | 11981788 | 8 | 20151009 | 20160131 | 0 | |
| 119817887 | 11981788 | 9 | 20151118 | 20160204 | 0 |